Literature DB >> 9402275

Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and insemination on pregnancy rates.

K W Fuh1, X Wang, A Tai, I Wong, R J Norman.   

Abstract

The optimal time period for intrauterine insemination (IUI) in relation to either luteinizing hormone (LH) surge or human chorionic gonadotrophin (HCG) administration leading to the best pregnancy rates has not been determined. In this study, 856 consecutive human menopausal gonadotrophin (HMG)-stimulated and 49 natural unstimulated IUI cycles carried out at a reproductive medicine unit affiliated with a tertiary centre were analysed in a retrospective fashion. There were three scenarios in the temporal relationship of the LH surge, HCG administration and artificial insemination. These were (group A) subjects who had an endogenous LH surge but were not given HCG; (group B) subjects who were given HCG after an observed LH surge, and (group C) subjects who were given HCG before the LH surge. The overall pregnancy rate (PR) was 16% per cycle. The PR was 9% in group A, 20% in group B and 14% in group C. The PR in group B was significantly better than group C (P = 0.04). In group B, the longer the time interval between the LH surge and HCG administration, the better the PR up to 20 h (P = 0.025); the timing of IUI based on the LH surge was not critical to the achievement of pregnancy within 3 days. In group C, PR improved with the increasing interval between HCG and IUI from <28 h up to 60 h. We conclude that a better PR is achieved if a spontaneous LH surge occurs before HCG administration, especially where the administration of HCG is delayed 8-20 h after an observed LH surge; the timing of IUI based on the LH surge is not critical to the achievement of pregnancy within 3 days.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402275     DOI: 10.1093/humrep/12.10.2162

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Timing of hCG administration does not affect pregnancy rates in couples undergoing intrauterine insemination using clomiphene citrate.

Authors:  Paul A Robb; Jared C Robins; Michael A Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

2.  Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation to the spontaneous LH surge on pregnancy rates.

Authors:  Rajeevi Madankumar; James Tsang; Martin L Lesser; Daniel Kenigsberg; Steven Brenner
Journal:  J Assist Reprod Genet       Date:  2005-04       Impact factor: 3.412

3.  Performing IUI Simultaneously with hCG Administration Does Not Compromise Pregnancy Rate: A Retrospective Cohort Study.

Authors:  Patsama Vichinsartvichai; Khanitta Traipak; Chirawattana Manolertthewan
Journal:  J Reprod Infertil       Date:  2018 Jan-Mar

4.  Controlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hCG Administration Than Spontaneous LH Surge.

Authors:  Evan Taerk; Edward Hughes; Cassandra Greenberg; Michael Neal; Shilpa Amin; Mehrnoosh Faghih; Megan Karnis
Journal:  J Reprod Infertil       Date:  2017 Jul-Sep

5.  The potential use of intrauterine insemination as a basic option for infertility: a review for technology-limited medical settings.

Authors:  Abdelrahman M Abdelkader; John Yeh
Journal:  Obstet Gynecol Int       Date:  2009

6.  Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.

Authors:  Mohamed F Mitwally; Sonya Abdel-Razeq; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2004-07-07       Impact factor: 5.211

7.  Preparation of the Endometrium for Frozen Embryo Transfer: A Systematic Review.

Authors:  Sezcan Mumusoglu; Mehtap Polat; Irem Yarali Ozbek; Gurkan Bozdag; Evangelos G Papanikolaou; Sandro C Esteves; Peter Humaidan; Hakan Yarali
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.